Teva Exits Astellas Patent Suit Over Cancer Drug
Astellas Pharma Inc. unit OSI Pharmaceuticals Inc., Genentech Inc. and Pfizer Inc. settled their infringement suit over generic versions of the cancer treatment Tarceva with Teva Pharmaceuticals USA Inc. in Delaware...To view the full article, register now.
Already a subscriber? Click here to view full article